The therapeutic potential of agents targeting the type I insulin-like growth factor receptor.
about
Optical imaging probes in oncologyProliferating endothelial cell-specific expression of IGF-I receptor ribozyme inhibits retinal neovascularization.Positive expression of insulin-like growth factor-1 receptor is associated with a positive hormone receptor status and a favorable prognosis in breast cancerDiscovery of OSI-906: a selective and orally efficacious dual inhibitor of the IGF-1 receptor and insulin receptor.Insulin receptor (IR) and insulin-like growth factor receptor 1 (IGF-1R) signaling systems: novel treatment strategies for cancer.Dual inhibition of epidermal growth factor receptor and insulin-like growth factor receptor I: reduction of angiogenesis and tumor growth in cutaneous squamous cell carcinoma.Analysis of the quantitative balance between insulin-like growth factor (IGF)-1 ligand, receptor, and binding protein levels to predict cell sensitivity and therapeutic efficacy.Drug efflux by breast cancer resistance protein is a mechanism of resistance to the benzimidazole insulin-like growth factor receptor/insulin receptor inhibitor, BMS-536924Targeting the PI3K/mTOR pathway in murine endocrine cell lines: in vitro and in vivo effects on tumor cell growthDoxorubicin plus the IGF-1R antibody cixutumumab in soft tissue sarcoma: a phase I study using the TITE-CRM model.Targeting the insulin-like growth factor axis as a cancer therapy.IGF1R inhibition in mammary epithelia promotes canonical Wnt signaling and Wnt1-driven tumorsHER receptor signaling confers resistance to the insulin-like growth factor-I receptor inhibitor, BMS-536924.Fluorescent tumour imaging of type I IGF receptor in vivo: comparison of antibody-conjugated quantum dots and small-molecule fluorophore.Impact of heat-shock protein 90 on cancer metastasisTargeted therapy in biliary tract cancer: 2009 update.Dual IGF-1R/InsR inhibitor BMS-754807 synergizes with hormonal agents in treatment of estrogen-dependent breast cancer.Targeted therapy in nonmelanoma skin cancers.Oral therapy for nonmelanoma skin cancer in patients with advanced disease and large tumor burden: a review of the literature with focus on a new generation of targeted therapies.Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA).Comparison of three approaches for inhibiting insulin-like growth factor I receptor and their effects on NSCLC cell lines in vitro.Targeted medical therapy of biliary tract cancer: recent advances and future perspectives.Treatment of gastrointestinal neuroendocrine tumors with inhibitors of growth factor receptors and their signaling pathways: recent advances and future perspectives.PQ401, an IGF-1R inhibitor, induces apoptosis and inhibits growth, proliferation and migration of glioma cells.
P2860
Q28067824-E85E6755-59F1-41D6-8C6E-8053F11326F0Q33232494-F39F4EE1-CFB9-4C15-B168-32AA51AC26DAQ33875800-4F1B5B1C-1C1B-4E84-B730-9C89F666E3ACQ34172489-8E98413D-4F14-419A-9DD4-4A4F222C677AQ34391968-89320948-4409-4415-A179-F7B44BE483A6Q34442002-1BBFB4E1-31DD-424E-B95D-82982C2EFA0BQ34539063-CBE8524D-AD6E-4963-98CF-69780FABCCC8Q34674256-06EAF2CC-6389-417D-8FE6-A114CAF89877Q34755871-8626E6FB-6666-4917-8F8D-46C5B23986E3Q35775234-2E93740E-BD63-403A-BC4D-DD762A599281Q36429684-CAC9ABAC-40CF-4D36-990D-BE9E03F9DFEEQ36664343-5AF1F1B5-FF9C-4A83-9220-EBEAC2261C36Q37038068-9BCBE9CD-99BD-47EB-B979-A15378CE28F1Q37269743-FC21978F-47EB-45EB-9EE7-A5082B993AFEQ37272247-918B4628-6795-4A29-876A-72179B4C2F2FQ37650623-4FDB3BCA-5A3D-4E46-8C3A-F525B68CBC1FQ37731144-164CB770-60D5-4995-B338-85170CE8B8DEQ38161358-57E3F7E7-422F-426F-93D2-D75DDC9C8D4DQ38633004-72475EE7-07F3-4074-867E-8730B3783020Q38812588-78805A17-CFC7-4023-ADCC-1A5B9C756944Q40142014-E4489CEC-98D5-404F-A1BC-831DA336A30DQ42635172-9AABB7AA-F2BA-4B05-9F6D-1809088125A2Q43097453-AC1342F9-6D2A-4A0B-A16E-1299A2E65579Q48179406-153DF04E-7DD2-470B-8BCB-B8C8B082C374
P2860
The therapeutic potential of agents targeting the type I insulin-like growth factor receptor.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
The therapeutic potential of a ...... n-like growth factor receptor.
@ast
The therapeutic potential of a ...... n-like growth factor receptor.
@en
type
label
The therapeutic potential of a ...... n-like growth factor receptor.
@ast
The therapeutic potential of a ...... n-like growth factor receptor.
@en
prefLabel
The therapeutic potential of a ...... n-like growth factor receptor.
@ast
The therapeutic potential of a ...... n-like growth factor receptor.
@en
P2860
P1476
The therapeutic potential of a ...... n-like growth factor receptor.
@en
P2093
Douglas Yee
P2860
P304
P356
10.1517/13543784.13.12.1569
P407
P577
2004-12-01T00:00:00Z